-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Anavex Life Sciences Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
- Anavex Life Sciences Corp. Operating Income (Loss) for the quarter ending December 31, 2024 was -$13.6M, a 19.5% decline year-over-year.
- Anavex Life Sciences Corp. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$55.1M, a 6.46% decline year-over-year.
- Anavex Life Sciences Corp. annual Operating Income (Loss) for 2024 was -$52.9M, a 5.16% increase from 2023.
- Anavex Life Sciences Corp. annual Operating Income (Loss) for 2023 was -$55.8M, a 9.36% decline from 2022.
- Anavex Life Sciences Corp. annual Operating Income (Loss) for 2022 was -$51M, a 21.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)